Physicians' Academy for Cardiovascular Education

CDMC 2016: T2DM management in high CV risk patients: What are the Facts and Opportunities?

Meeting report of the Cardio Diabetes Master Class (CDMC) held in november 2016 in Duba, UAE as an educational service for participants with video and slides.
CDMC 2016: T2DM management in high CV risk patients: What are the Facts and Opportunities?

3' Education

Review of cardiovascular safety of DPP4 inhibitors

3' education - May 6, 2016 - Dubai, UAE - Dr Sanjay Rajagopalan, MD, Maryland
##RIGHT_SECTION_ITEMS_FULL_TITLE##

Stroke reduction with PPAR-Y antagonist pioglitazone

3' education - May 6, 2016 - Dubai, UAE - Dr Robert J Chilton
##RIGHT_SECTION_ITEMS_FULL_TITLE##
CDMC 2016: T2DM management in high CV risk patients: What are the Facts and Opportunities?

Presentation Slides

New updates on PPARs and the diabetes heart

Slides (presentation) - May 6, 2016
##RIGHT_SECTION_ITEMS_FULL_TITLE##

Understanding the natural course of diabetes and CVD

Slides (presentation) - May 6, 2016
##RIGHT_SECTION_ITEMS_FULL_TITLE##

Are new DPP4 Outcome trials changing the fundamentals of diabetes management?

Slides (presentation) - May 6, 2016
##RIGHT_SECTION_ITEMS_FULL_TITLE##